Work

Frameshift mutations (Fsindel) complement tumor mutation burden (TMB) in predicting survival after immune checkpoint inhibitors (ICI) in a pancancer analysis.

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.15_suppl.2617

Authors: Vaia Florou, Wungki Park, Peter Joel Hosein, Breelyn A. Wilky, Jonathan C. Trent, Gilberto Lopes

Institutions: University of Miami, Sylvester Comprehensive Cancer Center, Memorial Sloan Kettering Cancer Center, University of Miami Health System

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2946976600

Cites:

Cited by: 1

Related to: 10